Ind-Swift Laboratories Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

Ind-Swift Laboratories Ltd: Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 24.8% to ₹191 crore against Jun 2025. Net profit rose 177.8% to ₹25 crore against the same period a year earlier. Operating margin rose from 2.6% to 17.3% (14.7 percentage points higher). A reported annual profit of ₹43 crore coincided with an operating cash outflow of ₹68 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 15 October 2026, 8:53 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price358₹ per share
Reported P/E47.8Times
Book value per share159₹ per share
Reported ROCE4.86 %Reported return

Stored market and accounting figures

Price record: 15 October 2026, 8:53 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap3,114 Cr.
Current Price358
High / Low425/87.0
Stock P/E47.8
Book Value159
Dividend Yield0.00 %
ROCE4.86 %
ROE4.02 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 24.8% to ₹191 crore against Jun 2025. Net profit rose 177.8% to ₹25 crore against the same period a year earlier. Operating margin rose from 2.6% to 17.3% (14.7 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 3102902885293312129138153153151170191
Expenses 2502242364374324135147149151147149158
Operating Profit 60665291-10-12-7-94142133
OPM % 19%23%18%17%-29%-99%-5%-7%2.4%1.0%2.8%12%17%
Other Income 677458111316220151822-37
Interest 20212130010-27121-21
Depreciation 14131420006777988
Profit before tax 32392452711-72301010161233
Tax % 45%18%19%6%-3%31%-16%4%17%22%42%-26%25%
Net Profit 17321949410-522298101525
EPS in Rs 2.925.363.2983.550.160.07-0.9336.671.450.981.171.742.84

Last Updated: September 29, 2026, 7:50 pm

EARNINGS

Annual performance

Mar 2026

Higher sales were accompanied by lower earnings in the year ending Mar 2026. Sales rose 13.1% to ₹649 crore against Mar 2025. Net profit fell 82.8% to ₹43 crore against the same period a year earlier. Operating margin rose from -1.2% to 7.2% (8.5 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 17, 2026, 3:07 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 6606537167657577808911,0391,2071,281574649665
Expenses 5715466106316306357098379781,029581602605
Operating Profit 89107106134126144183202229252-74760
OPM % 13%16%15%18%17%19%21%19%19%20%-1.2%7%9%
Other Income -311151612033233774342923644
Interest 117106882892107100969251311
Depreciation 8485888710490871315753243132
Profit before tax -143-83-553650-201813875822585171
Tax % -17%-29%-29%39%42%7%117%117%45%28%3%15%
Net Profit -119-59-392229-21-3-2484212504357
EPS in Rs -29.14-14.33-8.754.856.09-3.59-0.53-0.368.0671.2441.324.976.73
Dividend Payout % -0%-0%-0%-0%-0%-0%-0%-0%-0%-0%-0%-0%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)50.42%33.90%156.41%31.82%-172.41%85.71%33.33%2500.00%777.08%-40.62%-82.80%
Change in YoY Net Profit Growth (%)0.00%-16.52%122.51%-124.59%-204.23%258.13%-52.38%2466.67%-1722.92%-817.70%-42.18%

Growth

Compounded Sales Growth
10 Years:-2%
5 Years:-6%
3 Years:-19%
TTM:-62%
Compounded Profit Growth
10 Years:10%
5 Years:30%
3 Years:205%
TTM:-88%
Stock Price CAGR
10 Years:14%
5 Years:24%
3 Years:20%
1 Year:-32%
Return on Equity
10 Years:2%
5 Years:6%
3 Years:10%
Last Year:4%

Last Updated: September 5, 2025, 7:30 am

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹18 crore in Mar 2026. They decreased from ₹33 crore in Mar 2025 (45.5% lower). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 17, 2026, 3:07 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 424245464860606060596987
Reserves 5534764865075405815445416228721,1041,297
Borrowings 1,4131,4571,2421,0831,1481,0311,005953862173318
Other Liabilities 236240364387188198210247280217232271
Total Liabilities 2,2442,2152,1382,0231,9241,8701,8181,8011,8241,1651,4381,673
Fixed Assets 1,1171,0991,0429349148437536305878273304
CWIP 113787069201119108-0-012
Investments 181818181917362930111213248
Other Assets 9971,0201,0071,0029729981,0111,1311,1991,0479521,110
Total Assets 2,2442,2152,1382,0231,9241,8701,8181,8011,8241,1651,4381,673
CASH & FUNDING

Cash generation

Mar 2026

Operating activities used ₹68 crore in Mar 2026. Reported free cash flow for the same period was −₹155 crore. Negative operating cash flow means cash left the operating cycle; examine receivables, working capital and the reconciliation in the company filing before attributing a cause. Operating cash flow was negative in each of the last 3 consecutive stored annual periods. A reported annual profit of ₹43 crore coincided with an operating cash outflow of ₹68 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 98799673-64125135150195-163-29-68
Cash from Investing Activity + -35-29-31-17-12-9-105-13-104-113-69
Cash from Financing Activity + -64-48-69-62100-133-124-141-18669972142
Net Cash Flow -13-4-623-17114-4431-695
Free Cash Flow 59496352-79114131137182-205-54-155
CFO/OP 111%74%90%54%-51%87%73%74%85%-65%323%-131%
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 111%74%90%54%-51%87%73%74%85%-65%323%-131%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow59.0049.0063.0052.00-79.00114.00131.00137.00182.00-205.00-54.00-155.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 141 in Mar 2025. That is 139 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 16821520818219416918617716015348107
Inventory Days 1823123683052912843153012882426145
Days Payable 1031201379111811412411111811352140
Cash Conversion Cycle 2474074393963673393773673302822112
Working Capital Days 129141-26-97-492172482532532342141
ROCE %0%1%2%2%4%4%5%7%7%13%20%3%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 42.93% in Jun 2026. Their share was 1.99 percentage points higher than in Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 10.70% in Jun 2026, 6.43 percentage points above their holding in Jun 2025. DIIs held 0.17% in Jun 2026, 0.74 percentage points below their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 42.01%42.01%42.01%42.01%42.01%42.01%40.94%40.94%39.49%39.49%43.00%42.93%
FIIs 0.17%0.31%0.26%1.27%0.65%0.46%3.07%4.27%14.80%14.33%13.88%10.70%
DIIs 19.49%18.73%8.03%0.94%0.94%0.94%0.91%0.91%0.68%0.68%0.00%0.17%
Public 38.34%38.96%49.72%55.81%56.41%56.61%55.08%53.88%45.02%45.50%43.14%46.19%
No. of Shareholders 25,40524,63322,43925,46128,88328,75228,11728,70943,78042,12139,22240,881

This stock is not held by any mutual fund.

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 37.2571.248.10-0.36-0.53
Diluted EPS (Rs.) 35.2171.248.10-0.36-0.53
Cash EPS (Rs.) 40.0080.3517.5921.5514.07
Book Value[Excl.RevalReserv]/Share (Rs.) 170.88157.6483.3667.6165.66
Book Value[Incl.RevalReserv]/Share (Rs.) 170.88157.64114.02100.47100.90
Revenue From Operations / Share (Rs.) 81.71216.78201.87173.68149.04
PBDIT / Share (Rs.) 9.0250.7043.9239.9834.36
PBIT / Share (Rs.) 5.4641.6834.3318.0719.77
PBT / Share (Rs.) 37.5098.4614.472.103.01
Net Profit / Share (Rs.) 36.4471.338.00-0.35-0.52
NP After MI And SOA / Share (Rs.) 36.4471.247.96-0.35-0.52
PBDIT Margin (%) 11.0323.3821.7523.0123.05
PBIT Margin (%) 6.6719.2217.0010.4013.26
PBT Margin (%) 45.8945.417.161.202.02
Net Profit Margin (%) 44.6032.903.96-0.20-0.35
NP After MI And SOA Margin (%) 44.5932.863.94-0.20-0.35
Return on Networth / Equity (%) 21.3245.199.54-0.53-0.80
Return on Capital Employeed (%) 3.0826.0914.137.367.86
Return On Assets (%) 17.4136.132.60-0.11-0.17
Long Term Debt / Equity (X) 0.010.011.512.102.25
Total Debt / Equity (X) 0.020.011.732.352.56
Asset Turnover Ratio (%) 0.430.850.660.540.46
Current Ratio (X) 3.922.993.143.223.00
Quick Ratio (X) 3.412.941.961.941.81
Inventory Turnover Ratio (X) 9.015.701.521.331.23
Interest Coverage Ratio (X) 21.245.862.852.502.05
Interest Coverage Ratio (Post Tax) (X) 10.361.681.810.970.96
Enterprise Value (Cr.) 189.85165.501173.711328.011424.06
EV / Net Operating Revenue (X) 0.330.120.971.281.60
EV / EBITDA (X) 3.060.554.475.556.93
MarketCap / Net Operating Revenue (X) 1.030.450.270.380.48
Price / BV (X) 0.490.620.660.981.10
Price / Net Operating Revenue (X) 1.030.450.270.380.48
EarningsYield 0.430.720.14-0.01-0.01

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Ind-Swift Laboratories Ltd 3,114 Cr. 358 425/87.047.8 1590.00 %4.86 %4.02 % 10.0
Solara Active Pharma Sciences Ltd 3,150 Cr. 649 774/422738 3460.00 %4.86 %0.13 % 10.0
Advanced Enzyme Technologies Ltd 3,016 Cr. 269 420/25219.1 1461.98 %14.0 %10.2 % 2.00
Kwality Pharmaceuticals Ltd 3,443 Cr. 3,316 3,949/82942.2 3210.00 %23.9 %22.5 % 10.0
Hikal Ltd 2,671 Cr. 216 261/14663.0 97.20.28 %3.50 %2.21 % 2.00
Industry Average17,099.46 Cr1,203.8953.00211.250.40%26.15%16.59%6.06

All Competitor Stocks of Ind-Swift Laboratories Ltd